KLK3 and prostate carcinoma: α2,3-Linked sialylated prostate-specific antigen (PSA), a cancer-associated PSA glycosylation biomarker, and the Prostate Health Index outperformed PSA in identifying clinically significant prostate cancer in a single-center cohort.